J P Sloane

5.6k citations
69 papers · 3.2k indexed · h-index 32
Topics
Breast Lesions and Carcinomas (20 papers)Hematopoietic Stem Cell Transplantation (20 papers)Breast Cancer Treatment Studies (16 papers)

In The Last Decade

J P Sloane

69 papers receiving 3.1k citations

Peers

J P Sloane
Comparison fields: 5 of 96
  • Pathology and Forensic Medicine 1.2k
  • Cancer Research 1.1k
  • Oncology 1.1k
  • Molecular Biology 731
  • Dermatology 704
Replace John J. Zone with:
John J. Zone United States
K Hou-Jensen Denmark
Lydia Visser Netherlands
Xavier Sastre France
Tariq M. Murad United States
Harriette J. Kahn Canada
Pascal Chaubert Switzerland
Harald Stein Germany
Luciano Ozzello United States
Jeffrey F. Krane United States
J P Sloane relative to John J. Zone United States John J. Zone's profile →
Citations per field
00.5×3.5×
John J. Zone · 1×
Citations per year

Countries citing papers authored by J P Sloane

Since Specialization
Citations

This map shows the geographic impact of J P Sloane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J P Sloane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J P Sloane more than expected).

Fields of papers citing papers by J P Sloane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J P Sloane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J P Sloane. The network helps show where J P Sloane may publish in the future.

Co-authorship network of co-authors of J P Sloane

This figure shows the co-authorship network connecting the top 25 collaborators of J P Sloane. A scholar is included among the top collaborators of J P Sloane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J P Sloane. J P Sloane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 200
2
Columnar cell lesions of the breast
1
3 103
4 34
5 31
6 47
7 63
8 41
9 46
10 7
11 142
12 6
13 41
14 1
15 62
16 4
17 9
18 106
19 6
20 5

About J P Sloane

J P Sloane is a scholar working on Hematology, Dermatology and Pathology and Forensic Medicine, having authored 69 papers that have together received 3.2k indexed citations. Recurring topics across this work include Breast Lesions and Carcinomas (20 papers), Hematopoietic Stem Cell Transplantation (20 papers) and Breast Cancer Treatment Studies (16 papers). The work is most often cited by research in Dermatology (704 citations), Cancer Research (1.1k citations) and Pathology and Forensic Medicine (1.2k citations). J P Sloane has collaborated with scholars based in United Kingdom, United States and Netherlands. Frequent co-authors include M.G. Ormerod, Sunil R. Lakhani, C Jarvis, Michael R. Stratton, Nadine Collins, D. Ross Sibson, J Norton, Balvinder Shoker, Abeer M. Shaaban and Christopher S. Foster. Their work appears in journals such as The Lancet, Cancer and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026